These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7380967)

  • 21. Tritiation of vasopressin analogues and their metabolic fate after intravenous injection in the rat.
    Janáky T; László FA; Morgat JL
    Acta Med Hung; 1984; 41(1):43-54. PubMed ID: 6739223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antagonistic properties of tetra-substituted analog of vasopressin with selective antidiuretic effects].
    Myshliakova NV; Afanas'eva GA; Strazda GM; Papsuevich OS; Klusha NV; Chipens GI
    Biull Eksp Biol Med; 1992 Feb; 113(2):150-2. PubMed ID: 1611060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of iodinated vasopressin antagonists which retain high affinity for the vasopressin receptor.
    Moore ML; Huffman WF; Roberts GD; Rottschaefer S; Sulat L; Stefankiewicz JS; Stassen F
    Biochem Biophys Res Commun; 1984 Jun; 121(3):878-83. PubMed ID: 6331433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
    Chang P; Kimura K
    Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin.
    Szabó G; Tabakoff B; Hoffman PL
    J Pharmacol Exp Ther; 1988 Nov; 247(2):536-41. PubMed ID: 2972830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the neurohypophyseal hormone [8-arginine]vasopressin and its analog [7-(3,4-dehydroproline), 8-arginine]vasopressin in aqueous solution. An examination of the nonlabile protons by 1H nuclear magnetic resonance spectroscopy.
    Wyssbrod HR; Fischman AJ; Wittbold WM; Smith CW; Walter R; Schwartz IL
    Int J Pept Protein Res; 1981 Jan; 17(1):48-55. PubMed ID: 7228491
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of arginine-vasopressin-induced motor disturbances by a potent vasopressor antagonist.
    Burnard DM; Veale WL; Pittman QJ
    Brain Res; 1986 Jan; 362(1):40-6. PubMed ID: 2867814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoreactive vasopressin in bull seminal fluid.
    Lundin S; Toresson G
    Horm Metab Res; 1987 Dec; 19(12):629-31. PubMed ID: 3440568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
    László FA; Baláspiri L
    Acta Med Hung; 1986; 43(3):333-9. PubMed ID: 3588172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent patenting activities in the discovery and development of vasopressin V2 receptor agonists.
    Tsukamoto I
    Expert Opin Ther Pat; 2012 Jun; 22(6):579-86. PubMed ID: 22630566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological half-lives and organ distribution of tritiated 8-lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin in Brattleboro rats.
    Janáky T; Laczi F; László FA
    Ann N Y Acad Sci; 1982; 394():116-27. PubMed ID: 6960751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS determination of desmopressin acetate in human skin samples.
    Getie M; Neubert RH
    J Pharm Biomed Anal; 2004 Jun; 35(4):921-7. PubMed ID: 15193737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Shapiro MD; Kelleher SP
    Am J Nephrol; 1984; 4(4):260-1. PubMed ID: 6332534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of infusions of arginine vasopressin or 1-deamino-8-D-arginine vasopressin on common carotid vascular resistance in conscious, Long Evans rats.
    Gardiner SM; Compton AM; Bennett T
    Br J Pharmacol; 1989 May; 97(1):153-7. PubMed ID: 2720303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An excitatory effect of vasopressin on neuronal firing in the hippocampus: structure-activity studies.
    Mühlethaler M; Dreifuss JJ
    Adv Biochem Psychopharmacol; 1982; 33():527-31. PubMed ID: 6896955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.